1222 - Sequence # 4005 - 4110 | CHADS-VASc - CHF / NYHA Classification
1222 - Sequence # 4280 | Syncope
1222 - Sequence # 13765 | 12 Lead Electrocardiogram Findings
1222 - Sequence # 4110 - 4115 | HAS-BLED Drugs - Antiplatelet & NSAID
1222 - Sequence # 3231 | Rheumatic Heart Disease & Sequence # 3235 | Seizure Disorder
1222 - Inclusion Criteria
1222 - Section H. Coronary Anatomy
1122 - Sequence # 4110 - 4115 | HAS-BLED Drug - Antiplatelet & NSAID
1122 - Appropriate Use Criteria Metrics
1122 - Coding Multiple Procedures Under the Same Episode of Care
1122 - Sequence # 4105 | HAS-BLED Alcohol
1122 - Sequence # 6010 | Systemic Ventricular Systolic Pressure
1122 - Metric 37 | First Medical Contact - Device Time
1122 - Sequence # 7511 | Native Vessel Adjunctive Measurements Obtained
1022 - Sequence # 4105 | HAS-BLED Alcohol
1022 - Appropriate Use Criteria Metrics
1022 - Eligibility for Follow-Up Metric 307 | Patients with Acceptable Quality of Life Outcome at 30 Days Based on the KCCQ Summary Score
1022 - Sequence # 14732 | Shared Decision Making
1022 - Intra and Post Procedure Events
1022 - Inclusion | Exclusion Criteria
1022 - Sequence # 7835 | STEMI or STEMI Equivalent First Noted
0922 - Sequence # 4100 | HAS-BLED Risk Score: HAS-BLED Labile INR
0922 - Metric 18 | Risk Standardized Complications (All Defibrillator Implants)
0922 - Star Ratings Eligibility for Public Reporting
0922 - Sequence # 4100 | HAS-BLED Labile INR
0922 - Sequence # 8071 | Coronary Artery Compression
0922 - Sequence # 10207 | Medications Prescribed at Discharge - Statin Dose
0922 - Sequence # 5032 | Electrocardiac Assessment Results
0822 - Sequence # 8008 | Previously Treated Lesion
0822 - Sequence # 12342 Episode Event | Metric 45 In-Hospital Risk Standardized Rate of Bleeding [STEMI (pre-admit) and NSTEMI patients]
0822 - Sequence # 8070 | New Requirement for Dialysis
0822 - Sequence # 4095 | HAS BLED - Bleeding
0822 - Metric 307 | Patients with Acceptable Quality of Life Outcome at 30 Days Based on KCCQ Summary Score
0822 - Sequence # 10205 Discharge Medications Prescribed | Metric 4 - Proportion of ICD/CRT-D Implant Patients with LVSD, who were Prescribed ACE-I, ARB, or ARN
0822 - Sequence # 4095 | HAS-BLED Bleeding
0722 - Sequence # 9002 | Intra/Post Procedure Events - Bleeding
0722 - Going Beyond the Obvious in Metric Review - Part 2
0722 - Sequence # 8130 | RBC Transfusion
0722 - Sequence # 4070 | HAS BLED - Stroke
0722 - Sequence # 7065 | Concomitant Procedure
0722 - Metric 26 and Appropriate Use Criteria (AUC)
0722 - Sequence # 7210 & 7220 | Cumulative Air Kerma and Dose Area Product
Heart Failure (HF) v4 Accreditation Tool Orientation
Heart Failure (HF) v4 Accreditation Tool Orientation-UPDATED Non-CE
0622 - AUC - Acute Coronary Syndrome
0622 - Going Beyond the Obvious in Metric Review
0622 - Sequence # 8075 | Airway Event Requiring Escalation of Care
0622 - Sequence # 4055 | HAS BLED - Hypertension (Uncontrolled)
0622 - Sequence # 9002 | Intra/Post Procedure Events Occurred: Cardiac Perforation
0622 - Sequence # 4310 | Results of Angiography
0622 - Sequence # 5170 | Baseline Imaging Performed
Building Strong Relationships Between Hospitals and EMS
0522 - Sequence # 7400 | Indications for Cath Lab Visit
0522 - Sequence # 12295 | Thrombolytic | Metric 17 - Reperfusion Therapy
0522 - Sequence # 6060 | Qp/Qs Ratio
0522 - Metric 5 | Proportion of Left Atrial Appendage Occlusion Procedures Successful Excluding Those Procedures Cancelled
0522 - Sequence # 9002 | Intra/Post Procedure Events Occurred, Permanent Pacemaker
0522 - Metric 35 | Intra or Post Procedure Events and Metric 35
0522 - Sequence # 4070 | HAS-BLED Stroke
0422 - Metric 4 | Proportion of Left Atrial Appendage Occlusion Procedures Successful
0422 - Inclusion Criteria
0422 - Sequence # 7610 | PDA Minimum Luminal Diameter
0422 - Sequence # 14739 | His / Left Bundle Lead and Metric 31
0422 - Sequence # 13381 | Number of Diseased Vessels
0422 - Sequence # 4055 | HAS-BLED Hypertension (Uncontrolled)
0422 - Sequence # 8021 | (Severe Calcification)
0322 - LAA Device Removal During Base Procedure | Follow-Up Requirements
0322 - Inclusion Criteria
0322 - Sequence # 8140 | Other Vascular Complications Requiring Treatment
0322 - Sequence # 14739 | His/Bundle Pacing
0322 - Sequence # 13704 | Mitral Valve Disease
0322 - Inclusion Criteria | Re-do Pulmonary Vein Isolation
0322 - Sequence # 4561 | CSHA Clinical Frailty Scale
0222 - Inclusion Criteria of 2nd LAAO Procedure During Follow-Up Period
0222 - Metric 55 - Door-in | Door-out time
0222 - Sequence # 11101 | Post Dilitation of Transcatheter Pulmonary Valve
0222 - Sequence # 7630 and Metric 10 | Proportion of Defibrillator Lab Visits With an Unsuccessful Attempt to Place the Coronary Sinus/ Left Ventricular Lead
0222 - Sequence # 9002 | Intra/Post Procedure Events Occurred: (Vascular Complication - Minor)
0222 - Sequence # 9095 | Genitourinary Bleeding - Intra or Post-Procedure Event
0222 - Sequence #5263 | Prior Diagnostic Coronary Angiogram Without Intervention
0122 - Metric 34 | Proportion of Defibrillator Patients with a Primary Tachycardia Indication & a Bradycardia Indication
0122 - Sequence # 10205 | Discharge Medications Prescribed - ARNI
0122 - Sequence # 13843 & 13846 - 13847 | KCCQ-12 Performed & KCCQ Questions
0122 - Sequence # 4410 & 4420 | Attempt at Atrial Fibrillation Termination/DC Cardioversion
0122 - Sequence # 4410 | Attempt at Atrial Fibrillation Termination
0122 - Sequence # 7258 | Aortic Valvuloplasty Post Dilation Regurgitation
0122 - Sequence # 7325 | Arterial Cross Over
1221 - Fixing Error 1130
1221 - Metric 37 | First Medical Contact to Device Time
1221 - Sequence # 13331 | Anesthesia Type
1221 - Sequence # 14719 | Ventricular Fibrillation
1221 - Sequence # 4410 | Attempt at Atrial Fibrillation Termination
1221 - Sequence # 7820 & 7821 | PCI for Multi-Vessel Disease & Multi-Vessel Procedure Type
1221 - Sequence # 8000 | Cardiac Arrest
1121 - Intra/Post-Procedure Events | Coding Pericardial Effusion Complication
1121 - Public Reporting
1121 - Seq# 8520 & Seq# 8525 | Planned Strategy/Medication Strategy Reason - Amplatzer Amulet Device
1121 - Sequence # 10205 | Discharge Medications Prescribed - ARNI
1121 - Sequence # 7505, 7507, 7508 | Coronary Anatomy
1121 - Sequence # 7620 | PDA Classification
1121 - Sequence # 9002 | Intra/Post-Procedure Events Occurred - Bleeding: Hematoma at Access Site
1021 - Inclusion Criteria
1021 - Public Reporting
1021 - Sequence # 12246 | Atrial Fibrillation
1021 - Sequence # 7180 & 7190 | Cardioversion (CD) Performed During Procedure
1021 - Sequence # 7400 & 7405 | Indications for Cath Lab Visit & Chest Pain Symptom Assessment
1021 - Sequence # 8055 | Device Embolization
1021 - Sequence # 9002 | Intra/Post-Procedure Events Occurred - Ischemic Stroke
0921 - Sequence # 12447 | STEMI Type
0921 - Sequence # 13025 | Follow-up Cause of Death
0921 - Sequence # 13423 | Aortic Valve Calcification Severity and Sequence # 13471 | Aortic Valve Annular Calcification
0921 - Sequence # 4001 | Heart Failure
0921 - Sequence # 4440 | Attempt at Atrial Fibrillation Termination/Surgical Ablation
0921 - Sequence # 7010 | Procedure Type
0921 - Sequence # 8035 | Tamponade Requiring Pericardial Drainage
0821 – Metric 56 | Time to Primary PCI Among Transferred Patients
0821 – Section K. Intra/Post Procedure | Bleeding Events
0821 - Sequence # 14732 | Shared Decision Making
0821 - Sequence # 7002 | Procedure Start Time
0821 - Sequence # 7135 | Current Ablation Strategy/Convergent
0821 - Sequence # 8130 | RBC Transfusion
0821 – v3 | Provider Maintenance and Remediation
0721 - Metric # 46 | P2Y12- Inhibitor at Discharge
0721 - Sequence # 10200 - 10205 | Discharge Medications
0721 - Sequence # 14732 | Shared Decision Making
0721 - Sequence # 14737 | Primary Bradycardia Indication Present
0721 - Sequence # 4560| (Currently on Dialysis) and the Intra and Post Procedure Event - New Requirement for Dialysis
0721 - Sequence # 7295 & 7296 | Procedure Aborted/Procedure Aborted, Reason
0721 - Sequence # 7650 | PDA Closure - Outcome of Device
0621 - Section K. Intra/Post-Procedure Events | Cardiogenic Shock and Retroperitoneal Bleed
0621 - Seq# 14729 | Primary Tachycardia Indication Present
0621 - Sequence # 10025 | Discharge Atrial Rhythm
0621 - Sequence # 13160 - 13175 | Follow Up Event: Device Migration and Device Systemic Embolism
0621 - Sequence # 4026 | Single Ventricle
0621 - Sequence # 7065 | Concomitant Procedures Performed
0621 - Sequence # 7845 | First Device Activation Date/Time
0521 - Follow-Up One Year
0521 - Sequence # 12326 | PCI Indication
0521 - Sequence # 13165 | Follow-Up Events: Systemic Thromboembolism
0521 - v2.3 Inclusion Criteria
0521 - Sequence # 3200 | Chronic Lung Disease
0521 - Sequence # 9080 | Hemorrhage (Non-Access Site), Systemic Events
0521 - Metric # 8 | Aspirin at Discharge
0421 - Appropriate Use Criteria
0421 - Sequence # 12360 | Patient Type
0421 - Sequence # 14719 | Ventricular Fibrillation
0421 - Sequence # 4005 | CHA2DS2 - VASC Congestive Heart Failure
0421 - Sequence # 4600 | Left Atrial Appendage Intervention
0421 - Sequence # 9002 | (Intra/Post-Procedure Events Occurred - Vascular Complication - Minor)
0321 - Risk Standardized Mortality
0321 - Sequence # 10115 | Hospice Care
0321 - Sequence # 4065 | HAS-BLED - Abnormal Liver Function
0321 - Sequence # 4065 | HAS-BLED Risk Score - Abnormal Liver Function
0321 - Sequence # 8075 | Airway Event Requiring Escalation of Care
0321 - Sequence # 9002 | (Intra/Post-Procedure Events Occurred - Bleeding: Access Site)
0221 - Inclusion Criteria
0221 - Inclusion Criteria | Trial Study Populations
0221 - Sequence # 4060 | HAS-BLED - Abnormal Renal Function
0221 - Sequence # 5047 & 5048 | Procedure Start Date/Time
0221 - Sequence # 7410 & 7415 | Cardiovascular Instability/Instability Type
0221 - Sequence 10200 & 10205 | Discharge Medications
0121 - Metric 56 | Time to Primary PCI Among Transferred Patients
0121 - Sequence # 10116 | Cardiac Rehabilitation Referral
0121 - Sequence # 4015 | CHA2DS2-VASc LV Dysfunction
0121 - Sequence # 4060 | HAS-BLED - Abnormal Renal Function
0121 - Sequence # 5057 & 5058 | Procedure End Date/Time
0121 - Sequence # 9002 | New Requirement for Dialysis
1220 - Metric 55 | Door-In Door-Out Time
1220 - Sequence # 5004 | Pulmonary Valvuloplasty
1220 - Sequence # 7511 | Adjunctive Measurements Performed
1220 - Sequence # 8525 | Post-Procedure Medication Strategy - Reason
1220 - Sequence # 9185 | Hematoma at Access Site
1120 - Metric 34 | Aspirin at Discharge
1120 - Sequence # 3080 | Prior Cardiac Surgery
1120 - Sequence # 4110 & 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS
1120 - Sequence # 4110 and 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS
1120 - Sequence # 9275 | Packed Red Blood Cell Transfusion
1020 - Metric 56 | Time to Primary PCI Among Transferred Patients
1020 - Sequence # 4005 | (CHA2DS2-VASc CHF)
1020 - Sequence # 4410 & 4415 | Attempt at Atrial Fibrillation Termination and Pharmacologic Cardioversion
1020 - Sequence # 5010 & 5001 | Coding a PFO Closure when Performed with an ASD Closure
1020 - Sequence # 7810 & 10117 | LOC - PCI and LOC - Discharge
0920 - Inclusion Criteria
0920 - Sequence # 5130 | Fluoroscopy Time
0920 - Sequence # 5200 | Stress Test Performed
0920 - Sequence # 9105 | Phrenic Nerve Damage
0820 - Sequence # 12360 | Patient Type
0820 - Sequence # 5160 | Inotrope
0820 - Sequence # 7225 and 7250 | Intraprocedure Anticoagulation & Other
0820 - Sequence # 7295 | Procedure Aborted - Metric # 6
0720 - Sequence # 4565 & 4570 | (Cardiomyopathy & CM Type)
0720 - Sequence # 7035 | Indication for LAA Occlusion
0720 - Sequence # 8210 | Intra/Post-Procedure Events - Pneumothorax
0720 - Sequence # 9002 | Intra/Post-Procedure Events - Bleeding GI
0620 - Inclusion Criteria
0620 - Metric # 1 | Proportion of Patients Undergoing AFA w/Class I or Class II Guideline Based Indication
0620 - Metric 24 | Cardiac Catheterization Adverse Events
0620 - Metric 36 | High Intensity Statin at Discharge
0620 - Sequence # 14731 | Reason Pacing Indicated v2.3
0620 - Sequence # 9146 | Significant Coronary Artery Dissection
0520 - Sequence # 13050 | 45 Day Follow-Up - Transesophageal Echo Performed
0520 - Sequence # 7080/7090 | Atrial Septal Defect Closure Procedure
0520 - Sequence # 7820 | Multivessel Disease
0520 - Sequence # 7845 | First Device Activation Date and Time
0520 - Sequence # 9025 | Bradycardia Adverse Events
0420 - Sequence # 12360 | Patient Type
0420 - Sequence # 4026 | Single Ventricle
0420 - Sequence # 4045 | CHA2DS2-VASc Vascular Disease
0420 - Sequence # 7010 | Procedure Type
0420 - Sequence # 7065 | Concomitant Procedures
0420 - Sequence # 9990 | Event Occurred
0320 - Sequence # 10116 | Cardiac Rehab Referral
0320 - Sequence # 10116/Metric 21 | Cardiac Rehab Referral
0320 - Sequence # 13015 | Follow-Up Status: Deceased
0320 - Sequence # 7155 | Number of Veins Isolated
0320 - Sequence # 7630 and Metric 10 | Failure to Place CS/LV Lead
0320 - Sequence # 8070 | New Requirement for Dialysis
0220 - Inclusion Criteria
0220 - Sequence # 10200 & 10205 | Discharge Medications
0220 - Sequence # 3222 | Heart Failure
0220 - Sequence # 4345 | Reason Pacing Indicated
0220 - Sequence # 7305 | Device Margin Residual Leak
0120 - Metric # 40 | PCI In-Hospital Risk Standardized Bleeding
0220 - Sequence # 7850 | Patient Centered Reason for Delay
0120 - Metric # 12 | ACE-I or ARB for LVSD at Discharge
0120 - Sequence # 13060 | Follow-Up: Atrial Thrombus Detected
0120 - Sequence # 6985 - 6990 | Pre-Procedure Medication Administered
0120 - Sequence # 8160 | Unplanned Cardiac Surgery
"30-Day Follow-up Metric 2 and Metric 3: Where To Go When Things Go Wrong" - Non-CE
STS/ACC TVT Registry 30-Day Follow-up Metric 2 and Metric 3:  Where To Go When Things Go Wrong
An Overview of the Diabetes Collaborative Registry
An Overview of the Diabetes Collaborative Registry - Non-CE
An Overview of the PINNACLE Registry - Non-CE
CathPCI Registry Metric #45
CathPCI Registry Metric #45 - Non-CE
Engaging the Clinical Team to Develop a Quality Centered Program
Engaging the Clinical Team to Develop a Quality Centered Program - Non-CE
Getting Acquainted with the Cath PCI v5 Dataset
Getting Acquainted with the Cath PCI v5 Dataset
CathPCI Registry Metric #40 Risk Standardized Bleeding
CathPCI Registry Metric #40 Risk Standardized Bleeding - Non-CE
Heart Failure (HF) Accreditation Conformance Database and Calculated Measures
Heart Failure (HF) Accreditation Conformance Database and Calculated Measures Non-CE
Heart Failure v4 Accreditation Overview
Heart Failure v4 Accreditation Overview Non-CE
How Gaps in the Guidelines are Addressed in the AUC
How Gaps in the Guidelines are Addressed in the AUC - Non-CE
3.0 New Version - 2020 Quality Summit presentation (Non-CE)
ACC Reduce the Risk: PCI Bleed Quality Campaign – What the Data Show - 2020 Quality Summit presentation (Non-CE)
AFib Ablation “State of the Art” - 2020 Quality Summit presentation (Non-CE)
CathPCI & Chest Pain – MI Registry: Supporting Patients, Providers & Organizations - 2020 Quality Summit presentation (Non-CE)
Collaboration on Improving the Efficiency of Data Abstraction - 2020 Quality Summit presentation (Non-CE)
Coming Soon: ICD Registry Version 2.3 Update! - 2020 Quality Summit presentation (Non-CE)
Cutting Edge Care of PDA in Premature Low Birth Wight Babies - 2021 Quality Summit presentation (Non-CE)
2021 Onward & Upward! - 2021 Quality Summit presentation (Non-CE)
Cardiac Rehabilitation in the Inpatient Setting: Bridging the Gap - 2021 Quality Summit presentation (Non-CE)
The Economics of Accreditation - 2021 Quality Summit presentation (Non-CE)
Take your EMS-Hospital Relationship to the Next Level: It's Not a Date, It's a Marriage - 2021 Quality Summit presentation (Non CE)
The Ralph G. Brindis Lecture & Closing - 2021 Quality Summit presentation (Non-CE)
Changing Culture - 2021 Quality Summit presentation (Non-CE)
LAAO Procedure Decision Making and Patient Selection - 2021 Quality Summit presentation (Non-CE)
12 Lead ECG Training to Ensure Optimal Triage and Treatment of Patients with Acute Coronary Syndromes and Life-Threating Arrhythmias - 2021 Quality Summit presentation (Non-CE)
Best Practice Sharing - Using Data to Drive Improvement - 2021 Quality Summit presentation (Non-CE)
The Detail is in the Documentation- Risk Score and Adverse Event Coding - 2021 Quality Summit presentation (Non-CE)
Everything You Always Wanted to Know About the Composite Risk Model - 2021 Quality Summit presentation (Non-CE)
The NCDR and SVS VQI Registry Collaboration: Providing Data, Resources and Peer-to-Peer Interactions to Help Improve Quality of Care - 2021 Quality Summit presentation (Non-CE)
Own Your Data, Dollars and Outcome: Centralized Registry Pros and Cons from a Leadership Perspective - 2021 Quality Summit presentation (Non-CE)
Selling Quality ...Articulating the Valve Proposition and ROI of CV Registries and Accreditation - 2021 Quality Summit presentation (Non-CE)
Troubleshooting Your Way to Accurate Appropriate Use Criteria Indications - 2021 Quality Summit presentation (Non-CE)
What Drives Patient Selection for Afib Ablation - 2021 Quality Summit presentation (Non-CE)
Troponin Assays the 411 - 2021 Quality Summit presentation (Non-CE)
Chest Pain Management — How to Get the Compass to Stop Spinning and Find Direction - 2021 Quality Summit presentation (Non-CE)
Who Knew the Tricuspid Valve Would Be So Interesting? - 2021 Quality Summit presentation (Non-CE)
Isn’t Informed Consent the Same as SDM? - 2021 Quality Summit presentation (Non-CE)
Exploring the AFib Ablation Procedure - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — Dashboard Mania - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — A Participants' Perspective - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — Quality Improvement in Action - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — NCDR Fundamentals - 2021 Quality Summit presentation (Non-CE)
The New Normal: Innovative Approaches to Managing and Measuring Your Accreditation and Registry Workplace - 2021 Quality Summit presentation (Non-CE)
New Tools in the Toolbox to Fix the Pulmonary Valve - 2021 Quality Summit presentation (Non-CE)
A Case Study - CRT-P or CRT-D? - 2021 Quality Summit presentation (Non-CE)
Current and Future Role of Innovation in Healthcare - 2021 Quality Summit presentation (Non-CE)
Chest Pain-MI Registry: How to Navigate Rough Waters and Find Smooth Sailing - 2021 Quality Summit presentation (Non-CE)
Fine Tuning Processes - Best Practice Sharing - 2021 Quality Summit presentation (Non-CE)
Mississippi State of Mind - 2021 Quality Summit presentation (Non-CE)
Update on the Risk Model - 2021 Quality Summit presentation (Non-CE)
Pacing Indications/Guidelines and Pacing Modes - 2021 Quality Summit presentation (Non-CE)
Reduce the Risk: PCI Bleed Campaign Achievement Celebration and a Look at YOUR Next Steps - - 2021 Quality Summit presentation (Non-CE)
Sharing the Value of Registry Data - 2021 Quality Summit presentation (Non-CE)
PulsePoint in Cape Girardeau, Missouri: A Community Collaborate Project to Enhance Early Heart Attack Care - 2021 Quality Summit presentation (Non-CE)
The Midwest STEMI Consortium - 2021 Quality Summit presentation (Non-CE)
What’s New What’s Different? - 2021 Quality Summit presentation (Non-CE)
Disease Management: High Sensitivity Troponin - Chest Pain - 2020 Quality Summit presentation (Non-CE)
Hierarchical Risk Modeling – You Can Get This! - 2020 Quality Summit presentation (Non-CE)
How Gaps in the Guidelines are Addressed in the AUC - 2020 Quality Summit presentation (Non-CE)
IMPACT Data Can Unleash Program Excellence - 2020 Quality Summit presentation (Non-CE)
Measuring and Using Quality Outcomes from the AFib Ablation Registry: An Untapped Well - 2020 Quality Summit presentation (Non-CE)
New Kids on the Block — The Update Populations of the Chest Pain – MI - 2020 Quality Summit presentation (Non-CE)
Patient Navigator Program: Focus MI — It Takes a Village Lessons Learned - 2020 Quality Summit presentation (Non-CE)
Post Procedure Anticoagulation Medication Strategies and Variations - 2020 Quality Summit presentation (Non-CE)
Quality Care in the COVID-19 Era — The Best Practices Ping Pong Match - 2020 Quality Summit presentation (Non-CE)
Quality Improvement Application – Connecting the Clinical Team - 2020 Quality Summit presentation (Non-CE)
Shared Decision Making - 2020 Quality Summit presentation (Non-CE)
The COVID-19 Pandemic: Part 1 - 2020 Quality Summit presentation (Non-CE)
The COVID-19 Pandemic: Part 2 - 2020 Quality Summit presentation (Non-CE)
The Next Frontier: Heart Failure Outpatient Management - 2020 Quality Summit presentation (Non-CE)
The Roadmap to Excellence Accreditation will Help! - 2020 Quality Summit presentation (Non-CE)
The Value of Chest Pain Center Accreditation and Creating a Culture of Process Improvement - 2020 Quality Summit presentation (Non-CE)
The Why and How of Selecting an ICD Lead and Location - 2020 Quality Summit presentation (Non-CE)
TRANSFORM: LDL – C Risk, an ACC Initiative to Reduce ASCVD Risk Among Secondary Prevention Patients within the PINNACLE Registry - 2020 Quality Summit presentation (Non-CE)
Understanding the LAAO Registry Follow Up Processes - 2020 Quality Summit presentation (Non-CE)
Universal Principles of Leading Change Through ACC Quality Campaigns - 2020 Quality Summit presentation (Non-CE)
What’s New What’s Old in TVT Metrics - 2020 Quality Summit presentation (Non-CE)
WOW! Look What We’ve Done with Telemedicine as the New normal - 2020 Quality Summit presentation (Non-CE)
Introduction to Chest Pain - MI Registry v3
Introduction to Chest Pain - MI Registry v3 - Non-CE
Mastering Composite Performance Measures
Mastering Composite Performance Measures - Non-CE
Medication Review: DOACs vs. Warfarin
Medication Review: DOACs vs. Warfarin - Non-CE
Metric 1 PCI In-hospital Risk-adjusted Mortality
Metric 1 PCI In-hospital Risk-adjusted Mortality - Non-CE
Metric 39 PCI In-hospital Risk Adjusted Acute Kidney Injury
Metric 39 PCI In-hospital Risk-Adjusted Acute Kidney Injury - Non-CE
NCDR Domestic and International Onboarding
NCDR Domestic and International Onboarding - Non-CE
NCDR Inpatient Registry Overviews - CP-MI Registry - Non-CE
NCDR Registry Success "Starts Here"
NCDR Registry Success "Starts Here" - Non-CE
Regional Time Sensitive Care Coalitions Course
Regional Time Sensitive Care Coalitions Course - Non-CE
One Health System’s Best Practices: Abstracting Efficiencies & Quality Improvement Techniques - 2020 Quality Summit presentation (Non-CE)
Understanding Metrics
Understanding Metrics - Non-CE
Understanding the LAAO Registry Follow-Up Process
Understanding the LAAO Registry Follow-Up Process - Non-CE
What is a DQR? Rationale and Training
What is a DQR? Rationale and Training - Non-CE
What is a Quality Check? Rationale and Training
What is a Quality Check? Rationale and Training - Non-CE